About: Buprenorphine Transdermal Patches (BTDS) in Subjects With Osteoarthritis Pain. Includes a 52-week Extension Phase.

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Buprenorphine Transdermal Patches (BTDS) in Subjects With Osteoarthritis Pain. Includes a 52-week Extension Phase. Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

clinical trial

Attributes	Values
rdf:type	Item
description	clinical trial (en) ensayu clínicu (ast) klinisch onderzoek (nl) клінічне випробування (uk)
rdfs:label	Buprenorphine Transdermal Patches (nl) Buprenorphine Transdermal Patches (BTDS) in Subjects With Osteoarthritis Pain. Includes a 52-week Extension Phase. (en)
skos:prefLabel	Buprenorphine Transdermal Patches (nl) Buprenorphine Transdermal Patches (BTDS) in Subjects With Osteoarthritis Pain. Includes a 52-week Extension Phase. (en)
name	Buprenorphine Transdermal Patches (nl) Buprenorphine Transdermal Patches (BTDS) in Subjects With Osteoarthritis Pain. Includes a 52-week Extension Phase. (en)
title	wds:Q65390250-A5467732-796F-4A56-8A23-8B7C32A77F51
title	A Randomized, Double-Blind, Multicenter Study Evaluating The Safety and Efficacy of BTDS in Subjects With Moderate to Severe Osteoarthritis Pain. Includes a 52-Week Extension Phase. (en)
end time	wds:Q65390250-BC37E8BA-BB16-495A-BD84-37EC26C467CE
end time	2005-03-01 00:00:00Z (xsd:dateTime)
instance of	wds:Q65390250-5393E4AC-23DE-46D5-95B5-C8F04FD561F5
instance of	clinical trial
start time	wds:Q65390250-AB32E790-2F94-474E-8271-0578B673BDE2
start time	2004-01-01 00:00:00Z (xsd:dateTime)
country	wds:Q65390250-31C07F4C-0661-43ED-8755-E5998D9F2666
country	United States of America
research site	wds:Q65390250-3E588D03-4469-4EF5-B53A-CF3EA01B8A8E wds:Q65390250-C12B7290-A064-4647-AB04-5D8A41698B29
research site	Diablo Clinical Research Parkway Medical Center
research intervention	wds:Q65390250-4EF20221-3A25-4BE4-A864-679D251228CE
research intervention	buprenorphine
minimum age	wds:Q65390250-3146751A-3FDB-4F37-92EB-FBAFBF52E6B1
minimum age	40 (xsd:decimal)
medical condition	wds:Q65390250-EC0254EB-7AA9-4F7F-9D17-AA7ECC6CFF04
medical condition	osteoarthritis
number of participants	wds:Q65390250-1398DF75-65B8-425C-8D64-40C1484D0454
number of participants	188 (xsd:decimal)
study type	wds:Q65390250-7EB34EE8-3F01-4B7A-BF34-0771AA3D97C2
study type	interventional study
ClinicalTrials.gov ID	wds:Q65390250-AC18EB99-D8A1-4E9E-BF2B-1EE6468B7C48
ClinicalTrials.gov ID	NCT00320801
clinical trial phase	wds:Q65390250-6190A2B9-E721-4B69-B045-082E7D82FDC3
clinical trial phase	phase III clinical trial
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q65390250

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software